Concepedia
Statistics
Publications
3
Citations
79
H-Index
Active since
2015
Affiliations
Sun Yat-sen University(Current)
Sun Yat-sen University Cancer Center
Xiangchan Hong is an author at Sun Yat-sen University.
Publications per year
2015–2022
The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor
Xinru Chen, Xiangchan Hong, Gang Chen et al. · Translational Oncology · 2022 · 43 citations · Full text
Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
Qi Chen, Qi Quan, Lingyu Ding et al. · Oncotarget · 2015 · 22 citations · Full text
Clinical benefit of continuing crizotinib therapy after initial disease progression in Chinese patients with advanced ALK-rearranged non-small-cell lung cancer
Xiangchan Hong, Qi Chen, Lingyu Ding et al. · Oncotarget · 2017 · 14 citations · Full text
1–3 of 3